SPBC17D11.08 Antibody

What is SPBC17D11.08 and why is it relevant for research studies?

SPBC17D11.08 is an uncharacterized WD repeat-containing protein found in Schizosaccharomyces pombe (fission yeast) . The protein belongs to the WD repeat family, which is characterized by repeating units typically ending with tryptophan-aspartic acid (WD) dipeptides. These proteins are structurally significant as they often form beta-propeller structures that serve as platforms for protein-protein interactions in various cellular processes including signal transduction, transcriptional regulation, and cell cycle control. The study of SPBC17D11.08 provides insights into fundamental cellular processes in eukaryotic cells, particularly in relation to the conserved functions of WD repeat proteins across species. Research on this protein contributes to our understanding of protein structure-function relationships and evolutionary conservation across diverse organisms.

How are SPBC17D11.08 antibodies produced and validated for research applications?

SPBC17D11.08 antibodies are typically generated through immunization of host animals (predominantly rabbits) with either synthetic peptides corresponding to specific regions of the protein or with recombinant full-length protein . The production process follows these methodological steps:

• Antigen selection: Computational analysis identifies immunogenic regions of SPBC17D11.08

• Immunization: Host animals receive multiple injections of the antigen with adjuvants

• Serum collection: Antibody-containing serum is harvested from the host

• Purification: Antigen-affinity chromatography isolates specific antibodies

• Validation: Multiple assays confirm specificity and sensitivity

Validation typically involves:

Commercial SPBC17D11.08 antibodies undergo this rigorous validation to ensure they specifically recognize the target protein with minimal cross-reactivity.

What are the optimal conditions for using SPBC17D11.08 antibody in Western blot applications?

When using SPBC17D11.08 antibody for Western blot applications, researchers should implement the following methodological approach for optimal results:

• Sample preparation: Lyse S. pombe cells using glass bead disruption in a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% NP-40, and protease inhibitors. Heat denature samples at 95°C for 5 minutes in Laemmli buffer with reducing agent.

• Gel electrophoresis: Separate proteins on 10-12% SDS-PAGE gels, as the WD repeat-containing protein SPBC17D11.08 has a molecular weight that typically falls within this separation range.

• Transfer conditions: Use PVDF membranes with semi-dry transfer at 15V for 45 minutes or wet transfer at 100V for 1 hour in Towbin buffer supplemented with 20% methanol.

• Blocking: Block membranes with 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature to minimize background.

• Primary antibody incubation: Dilute SPBC17D11.08 antibody 1:1000 to 1:2000 in 1% BSA or 5% milk in TBST and incubate overnight at 4°C with gentle agitation .

• Detection system: HRP-conjugated anti-rabbit secondary antibody (1:5000 dilution) followed by ECL detection offers optimal sensitivity while maintaining low background.

These methodological parameters have been optimized based on the characteristics of the SPBC17D11.08 antibody and the specific properties of the WD repeat-containing target protein.

How can researchers design effective experimental controls when using SPBC17D11.08 antibody?

Designing rigorous controls is essential for interpreting results from experiments using SPBC17D11.08 antibody. Researchers should implement the following control strategy:

• Positive controls:

  • Wild-type S. pombe lysate known to express SPBC17D11.08

  • Recombinant SPBC17D11.08 protein (at least 85% purity as determined by SDS-PAGE)

  • Cells overexpressing tagged SPBC17D11.08 (e.g., with HA or FLAG tag)

• Negative controls:

  • SPBC17D11.08 deletion strain lysate (if available)

  • Pre-immune serum at equivalent dilution to antibody

  • Primary antibody omission

  • Competitive blocking with immunizing peptide/protein

• Specificity controls:

  • Knockdown validation using RNAi if deletion is lethal

  • Cross-species lysates to test for binding to homologs

  • Dot-blot titration to assess concentration dependence

• Procedural controls:

  • Loading control antibodies targeting housekeeping proteins

  • Molecular weight markers to confirm expected migration pattern

  • Multiple biological replicates to assess variability

By systematically implementing these controls, researchers can confidently attribute observed signals to specific SPBC17D11.08 binding rather than technical artifacts or cross-reactivity.

What are common issues when using SPBC17D11.08 antibody and their solutions?

Researchers may encounter several challenges when working with SPBC17D11.08 antibody. The following table outlines common issues and their methodological solutions:

For SPBC17D11.08 antibody specifically, researchers should be particularly attentive to protein extraction conditions from S. pombe cells, as WD repeat-containing proteins may require optimization of lysis buffers to ensure complete solubilization and preservation of native structure.

How should quantitative data from SPBC17D11.08 antibody experiments be analyzed?

When analyzing quantitative data from experiments using SPBC17D11.08 antibody, researchers should follow this methodological framework:

• Image acquisition: Capture images within the linear dynamic range of the detection system, avoiding pixel saturation that would compromise quantification accuracy.

• Software selection: Use specialized quantification software (ImageJ, Image Lab, etc.) with consistent settings across all analyses.

• Normalization approach:

  • For Western blots: Normalize SPBC17D11.08 signal to loading controls (e.g., GAPDH, tubulin, or total protein stains)

  • For immunofluorescence: Use cell area or nuclear staining as normalizing factors

  • For ELISA: Incorporate standard curves with recombinant protein

• Statistical analysis:

  • Perform at least three biological replicates for robust statistical analysis

  • Test for normality before applying parametric tests

  • Use appropriate statistical tests (e.g., t-test for two-group comparisons, ANOVA for multiple groups)

  • Report both p-values and effect sizes

• Data visualization:

  • Present normalized values with error bars indicating standard deviation or standard error

  • Include representative images alongside quantified data

  • Use consistent scaling across comparable experiments

For time-course experiments typical in fission yeast studies, researchers should apply repeated measures statistical approaches that account for the temporal nature of the data, similar to methods used in transcriptional analysis of temporal experiments .

How can SPBC17D11.08 antibody be utilized in chromatin immunoprecipitation (ChIP) studies?

SPBC17D11.08 antibody can be adapted for ChIP applications to investigate potential chromatin associations of this WD repeat-containing protein, following this advanced methodological approach:

• Crosslinking optimization: For S. pombe cells, use 1% formaldehyde for 15 minutes at room temperature, followed by quenching with 125mM glycine for 5 minutes.

• Chromatin fragmentation: Sonicate to achieve fragments of 200-500bp, verifying fragmentation by agarose gel electrophoresis.

• Immunoprecipitation conditions:

  • Pre-clear chromatin with protein A/G beads for 1 hour

  • Incubate 25-50µg chromatin with 2-5µg SPBC17D11.08 antibody overnight at 4°C

  • Include IgG control from the same species (rabbit)

  • Include input samples (10% of chromatin used for IP)

• Washing and elution:

  • Perform stringent washes with increasing salt concentrations

  • Elute protein-DNA complexes with SDS-containing buffer at 65°C

  • Reverse crosslinks at 65°C overnight

  • Treat with RNase A and Proteinase K

• DNA purification and analysis:

  • Purify DNA using column-based methods

  • Analyze by qPCR targeting suspected binding regions

  • For unbiased approach, perform ChIP-seq

If SPBC17D11.08 functions as part of a transcriptional complex, researchers should design primers targeting promoter regions of genes potentially regulated by the complex. For comprehensive analysis, integrate ChIP data with transcriptome data from the fission yeast dataset to identify correlations between binding and gene expression changes .

What experimental designs are optimal for studying SPBC17D11.08 protein interactions?

To characterize the protein interaction network of SPBC17D11.08, researchers should implement a multi-method approach:

• Affinity purification coupled with mass spectrometry (AP-MS):

  • Express epitope-tagged SPBC17D11.08 (FLAG, HA, or TAP tag) in S. pombe

  • Perform IP under native conditions using either the epitope tag antibody or the SPBC17D11.08 antibody

  • Analyze co-purified proteins by mass spectrometry

  • Validate interactions by reciprocal IP

• Proximity-based labeling:

  • Fuse SPBC17D11.08 to BioID or APEX2

  • Express fusion protein in S. pombe

  • Induce biotinylation of proximal proteins

  • Purify biotinylated proteins and identify by mass spectrometry

• Yeast two-hybrid (Y2H) screening:

  • Use SPBC17D11.08 as bait against a S. pombe cDNA library

  • Screen for positive interactions under increasing stringency

  • Confirm by directed Y2H with individual candidates

• Co-localization studies:

  • Co-immunostain for SPBC17D11.08 and candidate interactors

  • Perform proximity ligation assay (PLA) for specific pairwise interactions

  • Use FRET or BRET for dynamic interaction studies

• Functional validation:

  • Generate mutants disrupting specific protein-protein interfaces

  • Assess functional consequences through phenotypic assays

  • Perform epistasis analysis with interacting partners

This comprehensive approach leverages the strengths of complementary techniques to build confidence in identified interactions, as WD repeat-containing proteins typically function as scaffolds for multi-protein complexes with diverse cellular functions.

How can SPBC17D11.08 antibody be used in temporal gene expression studies?

For studying SPBC17D11.08 expression dynamics across different cellular states or time points, researchers should implement this integrative approach:

• Experimental design considerations:

  • Synchronize S. pombe cultures using established methods (nitrogen starvation/release or cdc25 temperature-sensitive mutants)

  • Collect samples at regular intervals covering the cell cycle or response period

  • Include biological replicates (minimum n=3) for statistical robustness

  • Process samples simultaneously to minimize batch effects

• Multi-level analysis strategy:

  • Protein level: Western blot with SPBC17D11.08 antibody

  • Transcript level: RT-qPCR or RNA-seq

  • Localization: Immunofluorescence with SPBC17D11.08 antibody

• Data integration approach:

  • Correlate protein levels with transcript abundance

  • Compare with publicly available datasets on S. pombe cell cycle

  • Integrate with the "Fission dataset" available in the MultiRNAflow R package

  • Use time-series analysis methods to identify significant patterns

• Visualization methods:

  • Plot normalized expression values against time

  • Overlay protein and transcript data on the same time axis

  • Use heatmaps to compare with other cell cycle-regulated genes

This integrative approach enables researchers to distinguish between transcriptional and post-transcriptional regulation of SPBC17D11.08 and place it within the broader context of cellular processes.

What methods can be used to study SPBC17D11.08 function in stress response pathways?

To investigate potential roles of SPBC17D11.08 in stress response pathways, researchers should utilize the following methodological framework:

• Stress condition panel:

  • Oxidative stress: H₂O₂ (0.5-2mM) or menadione (10-100μM)

  • Osmotic stress: Sorbitol (1-2M) or KCl (0.6-1.2M)

  • Thermal stress: Heat shock (37-42°C) or cold shock (10-16°C)

  • Nutrient limitation: Nitrogen starvation or glucose depletion

  • DNA damage: UV irradiation or hydroxyurea treatment

• Phenotypic characterization:

  • Growth assays comparing wild-type and SPBC17D11.08 mutant strains

  • Cell morphology and division pattern analysis

  • Viability measurements using vital dyes or colony formation

• Molecular response analysis:

  • SPBC17D11.08 protein levels and modifications using the antibody at defined time points

  • Subcellular localization changes by immunofluorescence

  • Interaction partner shifts using co-immunoprecipitation

  • Global transcriptome response using RNA-seq comparison between wild-type and mutant

• Pathway integration:

  • Epistasis analysis with known stress response factors

  • Phosphorylation state analysis under stress conditions

  • Integration with stress-responsive transcription factor binding data

This comprehensive approach will help determine whether SPBC17D11.08 plays regulatory, structural, or effector roles in specific stress response pathways, and whether these functions are conserved across different types of cellular stress.